Volume | 10,282 |
|
|||||
News | - | ||||||
Day High | 3.82 | Low High |
|||||
Day Low | 3.54 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Nutriband Inc | NTRB | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
3.54 | 3.54 | 3.82 | 3.55 | 3.65 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
102 | 10,282 | US$ 3.62 | US$ 37,218 | - | 1.53 - 5.9274 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
17:14:15 | 2 | US$ 3.51 | USD |
Nutriband Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
27.81M | 7.83M | - | 2.08M | -4.48M | -0.57 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Nutriband News
Date | Time | Source | News Article |
---|---|---|---|
4/25/2024 | 06:00 | GlobeNewswire Inc. | IBN Coverage Initiated for Nutriband Inc. |
2/12/2024 | 14:57 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
1/25/2024 | 15:40 | Edgar (US Regulatory) | Form 8-K - Current report |
1/23/2024 | 09:53 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial.. |
1/11/2024 | 16:07 | Edgar (US Regulatory) | Form 8-K - Current report |
12/29/2023 | 16:25 | Edgar (US Regulatory) | Form 8-K - Current report |
7/19/2023 | 14:53 | Edgar (US Regulatory) | Form RW - Registration Withdrawal Request |
7/14/2023 | 08:15 | Edgar (US Regulatory) | Form 8-K - Current report |
7/14/2023 | 08:00 | Edgar (US Regulatory) | Form RW - Registration Withdrawal Request |
7/05/2023 | 20:56 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NTRB Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.19 | 4.39 | 3.20 | 3.69 | 18,237 | -0.64 | -15.27% |
1 Month | 4.80 | 5.49 | 3.20 | 4.51 | 47,616 | -1.25 | -26.04% |
3 Months | 2.83 | 5.9274 | 2.22 | 3.94 | 47,622 | 0.72 | 25.44% |
6 Months | 2.00 | 5.9274 | 1.53 | 3.71 | 26,558 | 1.55 | 77.50% |
1 Year | 3.73 | 5.9274 | 1.53 | 3.50 | 29,737 | -0.18 | -4.83% |
3 Years | 5.48 | 12.32 | 1.53 | 9.18 | 436,234 | -1.93 | -35.22% |
5 Years | 5.48 | 12.32 | 1.53 | 9.18 | 436,234 | -1.93 | -35.22% |
Nutriband Description
Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products. |